CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio
Jun 29, 2020 07:00 am | Marisa Wexler MS
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor) as a treatment for cystic fibrosis (CF) in people 12 and older who have either two F508del mutations or one F508del mutation and one minimal function mutation in the CFTR gene. “We are delighted […]
The post CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio appeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario